Across TCGA pan-cancer cohorts, GCG RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of GCG’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where GCG RNA is repressed in tumor relative to normal tissue. In most cancer types GCG is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.
COAD, READ, and STAD are the cancer types where GCG tumor–normal differential expression is most reproducible.